US Stock MarketDetailed Quotes

ALGS Aligos Therapeutics

Watchlist
  • 23.670
  • +2.660+12.66%
Close Feb 14 16:00 ET
  • 22.550
  • -1.120-4.73%
Post 20:01 ET
84.93MMarket Cap-3.26P/E (TTM)

About Aligos Therapeutics Company

Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is engaged in in developing therapeutics for chronic liver diseases and viral infections. The firm is focused on the discovery and development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses, as well as leveraging its expertise in liver diseases to create targeted therapeutics for nonalcoholic steatohepatitis (NASH). The company was founded by Lucinda Quan and Lawrence M. Blatt on February 05, 2018 and is headquartered in South San Francisco, CA.

Company Profile

SymbolALGS
Company NameAligos Therapeutics
Listing DateOct 16, 2020
Issue Price15.00
Founded2018
CEODr. Lawrence M. Blatt,PhD
MarketNASDAQ
Employees66
Fiscal Year Ends12-31
Address1 Corporate Drive,2nd floor
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-800-466-6059
Websitehttp://www.aligos.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Lawrence M. Blatt,PhD
  • President, Chairman of the Board and Chief Executive Officer
  • 1.34M
  • Lesley Ann Calhoun
  • Chief Operating Officer, Executive Vice President, Chief Financial Officer and Principal Accounting Officer
  • --
  • Julian A. Symons, D.Phil.
  • Executive Vice President and Chief Scientific Officer
  • 836.32K
  • Margarita Chavez, J.D.
  • Director
  • --
  • Dr. Heather Elizabeth Preston, M.D.
  • Director
  • --
  • Dr. K. Peter Hirth, PhD
  • Independent Director
  • 60.40K
  • James Scopa
  • Independent Director
  • 67.90K
  • Dr. Bridget A. Martell, M.D.
  • Independent Director
  • 52.90K
  • Carole L. Nuechterlein, J.D.
  • Independent Director
  • 12.90K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
PILOT
831175
+30.00%
XINGANJIANG
873167
+29.99%
Beijing Highlander Digital Technology
300065
+20.05%
4
Hangzhou Gaoxin Materials Technology
300478
+20.02%
5
Shijihengtong Technology
301428
+20.01%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025